Showing results (241-250 of 618) with videos related to

Sort By:
Pageof 62
The British Journal of Dermatology|March 1, 2013
Assessment of skin barrier function in podoconiosis: measurement of stratum corneum hydration and transepidermal water lossJ S Ferguson, W E Yeshanehe, W Yeshanehe, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Interstitial foam cells in the nephrotic syndrome belong to the monocyte/macrophage lineageF Nolasco, J S Cameron, R Reuben, et al.
Transplantation|August 1, 1989
The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsiesM J Raftery, D Seron, G Koffman, et al.
Kidney International|August 1, 1997
Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failureY Wang, J R Pratt, B Hartley, et al.
Seminars in Oncology|September 11, 2022
The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic reviewA Muls, S Georgopoulou, E Hainsworth, et al.
The Prostate|February 1, 1995
Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograftA Billström, I Lecander, F Dagnaes-Hansen, et al.
The Journal of Experimental Medicine|November 6, 2002
Failure to censor forbidden clones of CD4 T cells in autoimmune diabetesSylvie Lesage, Suzanne B Hartley, Srinivas Akkaraju, et al.
Cancer Research|June 1, 1992
The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancersT Ichikawa, J C Lamb, P I Christensson, et al.
The Prostate|January 1, 1985
Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-rM Hasenson, B Hartley-Asp, C Kihlfors, et al.
Pharmacology & Therapeutics|December 1, 1992
Preclinical and clinical perspectives on the use of estramustine as an antimitotic drugK D Tew, J P Glusker, B Hartley-Asp, et al.
Pageof 62